Cleveland, OHNCT06075264Now EnrollingIRB Ready

Vulvar Cancer Clinical Trial in Cleveland, OH

Access cutting-edge vulvar cancer treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by Frantz Viral Therapeutics, LLC

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions…

Expert Care in Cleveland

Access vulvar cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related vulvar cancer treatment provided free

Apply for This Cleveland Location

Check if you qualify for this vulvar cancer clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Vulvar Cancer Study in Cleveland

This is a phase II double-blind, placebo-controlled study of artesunate ointment for the treatment of HPV-associated vulvar HSIL (usual type vulvar intraepithelial neoplasia 2/3).

Sponsor: Frantz Viral Therapeutics, LLC

Who Can Participate

Inclusion Criteria

Adult women age ≥ 18 years
Capable of informed consent
Able to collaborate with planned follow-up (transportation, compliance history, etc)
Biopsy diagnosis of high-grade vulvar dysplasia (VIN2, VIN3, VIN2/3, HSIL), including both new and recurrent disease. A biopsy diagnosis of vulvar high-grade squamous intraepithelial lesion within the previous 3 months which was not excised or otherwise treated may be accepted for study entry.
Positive HPV test at study entry (any genotype).
Women of childbearing potential agree to use birth control during the dosing phase (through week 8).
Laboratory values at Screening of:
Serum alanine transaminase (SGPT/ALT) \< 5 x upper limit of normal (ULN)
Serum aspartate transaminase (SGOT/AST) \< 5 x ULN
Serum Bilirubin (total) \< 2.5 x ULN
Serum Creatinine ≤ 1.5 x ULN
Weight ≥ 50kg

Exclusion Criteria

Pregnant and nursing women
Concurrent anal, vulvar, or cervical cancer
HIV-positive participan

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT06075264) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Vulvar Cancer Treatment Options in Cleveland, OH

If you're searching for vulvar cancer treatment options in Cleveland, OH, this clinical trial (NCT06075264) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced vulvar cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH